IMU-131,trastuzumab
Imugene,roche
[]
#gi23 [dr. tanuj chawla] vaccines in gi cancers!!
herizon: her-vaxx + chemo vs. chemo in pts with her2+ mg/gej adeno os benefit 14 mo vs. 8.3 mo (hr 0.56) generates more questions: is there a role in pts after prior trastuzumab? how does her-vaxx compare to trastuzumab? 
Oncologist | Focus on #NETs | she/her 
Division Chief, GI Oncology @YaleCancer | Consultant Editor @JCO_ASCO |
Tweets mine | ASCO FCOI: https://t.co/UuqIAQ54sX